Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Directa Plus said it had been granted a patent relating to the company's unique manufacturing process, by the United States Patent and Trademark Office.
The new US patent covers Directa Plus' process for manufacturing graphene nanoplatelets using a water-based exfoliation technology.
'The manufacturing process allows the Company to engineer a wide range of particle morphologies that can be tailored to the particular requirements of end-user customers,' the company said. 'In addition, the 100 per cent production yield means that Directa Plus can manufacture products in large volumes at attractive price'
'This provides a significant competitive advantage, enabling the Company to integrate effectively and quickly with customers' large supply chains.'
At 9:43am: (LON:DCTA) Directa Plus Plc share price was +1p at 84p